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Articles
Eﬀ ect of a lifestyle intervention on weight change in south 
Asian individuals in the UK at high risk of type 2 diabetes: 
a family-cluster randomised controlled trial
Raj S Bhopal, Anne Douglas, Sunita Wallia, John F Forbes, Michael E J Lean, Jason M R Gill, John A McKnight, Naveed Sattar, Aziz Sheikh, 
Sarah H Wild, Jaakko Tuomilehto, Anu Sharma, Ruby Bhopal, Joel B E Smith, Isabella Butcher, Gordon D Murray
Summary
Background The susceptibility to type 2 diabetes of people of south Asian descent is established, but there is little 
trial-based evidence for interventions to tackle this problem. We assessed a weight control and physical activity 
intervention in south Asian individuals in the UK.
Methods We did this non-blinded trial in two National Health Service (NHS) regions in Scotland (UK). Between 
July 1, 2007, and Oct 31, 2009, we recruited men and women of Indian and Pakistani origin, aged 35 years or older, 
with waist circumference 90 cm or greater in men or 80 cm or greater in women, and with impaired glucose tolerance 
or impaired fasting glucose determined by oral glucose tolerance test. Families were randomised (using a random 
number generator program, with permuted blocks of random size, stratiﬁ ed by location [Edinburgh or Glasgow], 
ethnic group [Indian or Pakistani], and number of participants in the family [one vs more than one]) to intervention 
or control. Participants in the same family were not randomised separately. The intervention group received 15 visits 
from a dietitian over 3 years and the control group received four visits in the same period. The primary outcome was 
weight change at 3 years. Analysis was by modiﬁ ed intention to treat, excluding participants who died or were lost to 
follow-up. We used linear regression models to provide mean diﬀ erences in baseline-adjusted weight at 3 years. This 
trial is registered, number ISRCTN25729565.
Findings Of 1319 people who were screened with an oral glucose tolerance test, 196 (15%) had impaired glucose 
tolerance or impaired fasting glucose and 171 entered the trial. Participants were in 156 family clusters that were 
randomised (78 families with 85 participants were allocated to intervention; 78 families with 86 participants were 
allocated to control). 167 (98%) participants in 152 families completed the trial. Mean weight loss in the intervention 
group was 1·13 kg (SD 4·12), compared with a mean weight gain of 0·51 kg (3·65) in the control group, an adjusted 
mean diﬀ erence of –1·64 kg (95% CI –2·83 to –0·44).
Interpretation Modest, medium-term changes in weight are achievable as a component of lifestyle-change strategies, 
which might control or prevent adiposity-related diseases. 
Funding National Prevention Research Initiative, NHS Research and Development; NHS National Services Scotland; 
NHS Health Scotland.
Introduction
The susceptibility to type 2 diabetes of people of south Asian 
descent was established in the UK in 1985.1 There is little 
trial-based evidence for interventions to tackle this 
problem2–4 although existing consensus guidelines 
emphasise weight management through dietary change 
and physical activity.3,5,6 This approach has been shown to be 
eﬀ ective in 3-year intervention trials of diabetes prevention 
programmes in other ethnic groups in several countries 
including China,7 Finland,8 the USA,9 and India,2 and is, 
arguably, cost eﬀ ective.10 Systematic reviews show that 
achieving sustained weight management (with or without 
increased physical activity) is diﬃ  cult.11,12 Intensive lifestyle 
interventions, however, can reduce progression from 
prediabetes (impaired glucose tolerance or impaired fasting 
glucose, or both) to diabetes by up to 60% over 3 years.10,13,14
Two lifestyle intervention trials are particularly relevant 
to people from south Asia. In the US Diabetes Prevention 
Programme,9 eﬀ ects were shown across all ethnic groups, 
including Asians (a mix of ethnic groups, including 
some south Asian individuals). Participants in the Indian 
Diabetes Prevention Programme showed slight weight 
gain overall but had a 28·5% reduced risk of progression 
to diabetes.2 A systematic review of four pragmatic 
interventions suggested some promise and called for 
culturally tailored trials.4
The Prevention of Diabetes and Obesity in South 
Asians (PODOSA) study aimed to test the eﬀ ectiveness 
of a family-based 3-year programme promoting weight 
loss and increased physical activity in individuals of 
south Asian descent living in the UK.
Methods
Study design and participants
We did this non-blinded, family-cluster randomised 
controlled trial in the National Health Service (NHS) 
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Lothian and NHS Greater Glasgow and Clyde Health 
Board regions (Scotland, UK). We identiﬁ ed participants 
at high risk of developing diabetes through screening 
using an oral glucose tolerance test. Recruitment into 
screening used a multipronged approach and took 
place between July 1, 2007, and Oct 31, 2009.15 
Recruitment via the NHS included direct referrals from 
health-care professionals and written invitations to 
potential recruits via general practices. Recruitment 
within the community was done by the research team 
and through partnerships (including small payment) 
with local south Asian organisations and individuals. 
Participants were encouraged to refer friends and 
family throughout the recruitment period. Self-
identiﬁ ed men and women of Indian or Pakistani 
origin aged 35 years or older were eligible for screening 
if: their waists measured 90 cm or greater in men and 
80 cm or greater in women; there was no diagnosis of 
diabetes (other than gestational diabetes); and the 
family cook was cooperative. The age and waist size 
cutoﬀ s were to target screening at those at higher risk 
of impaired glucose tolerance or impaired fasting 
glucose. Participants receiving long-term oral 
corticosteroids, or weight loss medication, or with 
health disorders making adherence contraindicated or 
improbable, or pregnant, or who were unlikely to 
remain in the UK for 3 years, were excluded.
Screening participants were enrolled into the full trial 
if they had impaired glucose tolerance or impaired 
fasting glucose according to WHO criteria.16 We invited 
adult relatives (known as family volunteers) to support 
participants in behaviour change. Eligible family 
volunteers were aged 18 years or older and reported 
interacting with participants at least weekly.
Individuals gave written, informed consent before 
undertaking screening and participants and family 
volunteers gave written, informed consent to trial 
dietitians before randomisation. Ethics approval was 
granted by the Scotland A Research Ethics Committee 
(07-MRE10-2). Outcomes were reviewed annually by a 
Data Monitoring and Ethics Committee.
Randomisation and masking
We mapped each extended family unit. First degree 
relatives (parents, siblings, children) living in the same 
city were not randomised separately. The randomised 
family consisted of the participant (or participants) plus 
any family volunteers. Families were randomised in a 
1:1 ratio to intervention or control. Randomisation lists 
were produced by the trial statistician (GDM) using a 
random number generator program. Permuted blocks 
were used and block size varied randomly. Stratiﬁ cation 
was by location (Edinburgh or Glasgow), ethnic group 
(Indian or Pakistani), and number of participants in the 
family (one vs more than one). When an eligible 
participant was recruited, the study manager sent an 
e-mail to the trial statistician, who replied giving the 
randomised group allocation. There was no masking of 
group status except for the 3-year measure of weight, 
waist size, and hip size by independent research nurses.
Procedures
The intervention was consultation with a dietitian; both 
participants and family volunteers were part of this 
intervention (appendix pp 5–10 summarise the contents 
of the intervention). Dietitians were trained in 
venepuncture, anthropometric and blood pressure 
measurement, delivery of information, behaviour 
change using the stages of change model,17 and 
promotion of physical activity. Each family was mostly 
seen by the same dietitian throughout the study.
Families in the intervention group had 15 visits from 
a dietitian over 3 years (baseline, monthly for the ﬁ rst 
3 months, then every 3 months (which is comparable 
with previous similar trials2,7,8). The dietitians advised 
participants and family volunteers on achieving weight 
loss through a calorie-deﬁ cit diet and physical activity 
of at least 30 min daily brisk walking, using culturally 
Figure 1: Trial proﬁ le
*Two family volunteers did not have their weight measured at 3 years because of pregnancy.
196 eligible  
25 excluded
 16 did not meet inclusion criteria 
  9 declined to participate 
   
171 participants randomised 
 (with 124 family volunteers; 
 156 families)
Participants
1 lost to follow-up 
1 died 
1 moved away
 
Family volunteers  
1 lost to follow-up 
1 moved away 
2 pregnant* 
(3 families lost to follow-up) 
Participants
1 lost to follow-up
 
Family volunteers 
1 lost to follow-up 
1 withdrew from study 
(1 family lost to follow-up)  
85 participants assigned to intervention, 
 with 55 family volunteers (78 families)   
86 participants assigned to intervention, 
 with 69 family volunteers (78 families)   
84 participants analysed, with 53 family
  volunteers (77 families)   
83 participants analysed, with 65 family 
 volunteers (75 families)
1319 individuals screened for 
 eligibility 
1123 ineligible
 972 normoglycaemic 
 102 diabetes 
  49 other
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adapted and translated resources, including the 
Counterweight Programme.18 Details of cultural 
adaptation are reported elsewhere.19 Other advice 
included information on shopping and cooking (with 
demonstrations). 3-day food diaries and a dietary 
patterns questionnaire were used to collect data to 
inform dietitians’ advice. Participants were invited to 
attend annual group sessions, including a food 
shopping tour and brisk walking. Pedometers were 
given to the participants to provide step counts for 
motivation through self-monitoring and for the 
dietitians to assess progress. Bodyweight and waist 
circumference data, and the Chester step test,20 were 
used as motivational devices by dietitians.
The control group was given standardised written and 
verbal advice on healthy eating, diabetes prevention, 
promotion of physical activity, and on accessing other 
weight control and physical activity services over four 
visits (baseline, then annually) with a dietitian. This 
advice aimed to halt increasing weight.21
In both the intervention and control groups family 
volunteers were asked to follow the advice given and to 
help the participants to follow it.
For all participants, at the 1-year, 2-year, and 3-year 
visits dietitians collected anthropomorphic data (weight 
[to the nearest 100 g] and height, and hip and waist 
circumferences [to the nearest cm]), and blood samples 
following standard operating procedures. At the 3-year 
visit, dietitians administered a 75 g oral glucose 
tolerance test and research nurses masked to study 
group repeated the anthropometric measurements. 
The nurses’ measurements were used for the primary 
outcome analysis. Dietitians’ measurements were used 
for all secondary outcomes. The oral glucose tolerance 
test followed standardised procedures, with venous 
blood taken after an overnight fast of 10–16 h and 2 h 
after glucose load, and was analysed in accredited 
laboratories. Weight, height, and waist and hip 
circumferences were measured at baseline and annually 
in family volunteers.
Physical activity was assessed in participants only by 
the short form of the International Physical Activity 
Questionnaire (IPAQ).22 Data were also collected for 
prescribed medications and for adverse outcomes 
perceived by participants to be related to the 
intervention. We sought consent from participants to 
access information about diagnosis and diabetes from 
their general practitioners.
We did a cost analysis from a societal perspective, 
including health-service costs and the opportunity cost 
of time for trial participants. We excluded initial 
screening and trial recruitment costs. Health-service 
costs were the number and length of visits reported by 
dietitians and health-service use reported by 
participants. We valued dietitians’ time using NHS 
salary and overheads and general practitioner visits and 
hospital clinic attendances using NHS unit costs.23 
Intervention group Control group
Family-level summary
Number of families 78 (100%) 78 (100%)
One recruit with IGT or IFG 71 (91%) 72 (92%)
Two recruits with IGT or IFG 7 (9%) 5 (6%)
Four recruits with IGT or IFG 0 1 (1%)
Number of families with family volunteers 41 (53%) 44 (56%)
Individual-level summary, trial participants
Number of individuals with IGT or IFG 85 (100%) 86 (100%)
Sex
Men 39 (46%) 39 (45%)
Women 46 (44%) 47 (45%)
Age (years)
Mean (SD) 52·8 (10·2) 52·2 (10·3)
Range 37–80 35–78
Location
Glasgow 66 (78%) 66 (77%)
Edinburgh 19 (22%) 20 (23%)
Ethnic group
Indian 29 (34%) 28 (33%)
Pakistani 56 (66%) 58 (67%)
Religion
Muslim 55 (65%) 59 (69%)
Hindu 6 (7%) 9 (10%)
Sikh 23 (27%) 16 (19%)
Other 1 (1%) 2 (2%)
Family cook was a participant 43 (51%) 42 (49%)
Family history of diabetes 60 (71%) 60 (70%)
Years lived in UK 32·0 (12·7) 30·8 (13·5)
Education
No qualiﬁ cations 32 (38%) 24 (28%)
School level 23 (27%) 26 (30%)
Further or higher 30 (35%) 36 (42%)
Currently smokes or chews tobacco 6 (7%) 5 (6%)
Currently drinks alcohol 8 (10%) 10 (12%)
Vegetarian 12 (15%) 12 (14%)
Min physical activity per day (median [IQR])
MET.min* 446 (66–1095) 281 (120–660)
Total (moderate, vigorous, walking) 125 (20–300) 75 (30–180)
Moderate and vigorous only 0 (0–60) 0 (0– 60)
Walking only 60 (0–210) 50 (0–100)
Sitting time (h per day) 6 (4–8) 6 (4–9)
Number achieving 30 min total activity per 
day
32 (38%) 17 (20%)
Number achieving 150 min total activity per 
week
39 (46%) 24 (28%)
IPAQ activity category
Low 51 (60%) 69 (80%)
Moderate 32 (38%) 14 (16%)
High 2 (2%) 3 (3%)
Height (cm) 161·3 (10·5) 162·5 (7·8)
Weight (kg) 79·8 (16·2) 80·7 (15·0)
BMI (kg/m²) 30·6 (5·0) 30·5 (4·6)
Waist circumference (cm) 102·7 (11·2) 103·3 (11·0)
(Continues on next page)
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Participants’ time included the dietitians’ visits, time 
for moderate physical activity (from IPAQ), and the 
household’s time for food shopping and meal 
preparation as reported by participants to dietitians. We 
used median hourly wages by sex and ethnicity reported 
by the National Equality Panel–Labour Force Survey.24 
Cost was calculated using a 3·5% annual rate of 
discount and reported using 2011 pay and price levels.
Outcomes
When the trial was designed, we intended that the 
primary outcome would be incidence of type 2 diabetes. 
However, after recruitment to the trial started in 2007, 
we noted that recruitment to screening was slower than 
expected and the prevalence of impaired glucose 
tolerance and impaired fasting glucose was lower than 
predicted, making it diﬃ  cult to obtain the necessary 
sample size. The primary outcome of the trial was, 
therefore, altered on June 29, 2009, to change in weight 
at 3 years to ensure suﬃ  cient statistical power, in 
agreement with the Trial Steering Committee, Data 
Monitoring and Ethics Committee, and funders. Weight 
change at 3 years was included in the original protocol 
as a secondary outcome. Despite the amendment, the 
trial name, PODOSA, was retained.25
In the revised protocol, the secondary outcomes in 
participants were: changes in oral glucose tolerance 
test, progression to type 2 diabetes, BMI, waist 
circumference, and hip circumference, all at 3 years. 
HbA1c was not measured because its use for diagnosis 
of diabetes was introduced in the UK after the trial had 
commenced.  Secondary outcomes in family volunteers 
were change in weight, BMI, and waist and hip 
circumference at 3 years. Cost eﬀ ectiveness of the 
intervention was included as a secondary outcome; 
however, as a full analysis was not possible with the 
trial data, we report here only within-trial costs.
Statistical analysis
When the protocol was amended in 2009, we knew that 
the number of families with more than one person 
recruited with impaired fasting glucose or impaired 
glucose tolerance was small, so the new power 
calculation did not take clustering into account. A 
sample of 150 people assessed at 3 years gave 86% 
power to detect a mean diﬀ erence in weight of 2·5 kg 
between the two groups, assuming an SD of 5 kg with a 
two-sided 5% signiﬁ cance level.
Analyses were by modiﬁ ed intention to treat, excluding 
participants who died or were lost to follow-up, following a 
written analysis plan. In estimating the intraclass 
correlation coeﬃ  cient the relevant variance component 
was negative, so by convention, the estimated intraclass 
correlation was taken to be zero. The primary outcome was 
analysed using a random eﬀ ects, linear regression model 
with maximum likelihood estimation. The model was 
adjusted for the stratiﬁ cation variables of ethnicity and 
location. Change over time was incorporated by adjusting 
for baseline values in the model. The analysis did not 
include time as a ﬁ xed eﬀ ect. Since the primary outcome 
measure was weight loss at 3 years, only the baseline 
weights and 3-year weights were included in the main 
analysis. Intervention or control group was a ﬁ xed eﬀ ect. 
Results for continuous variables include an adjusted (for 
ethnicity and location) mean diﬀ erence between baseline 
and 3 years, with a 95% CI and corresponding p value. For 
proportions, we ﬁ tted a generalised linear mixed model 
with terms for stratiﬁ cation variables and intervention or 
control group as described.
The time and costs related to dietitians, costs related 
to general practitioner and hospital outpatients, and 
participants’ opportunity costs were described (without 
inferential statistics) by year and for the 3 years 
combined as appropriate. The conditional mean cost 
comparison between groups was modelled using linear 
regression and generalised linear parametric methods. 
We generated a bias-corrected bootstrap estimate of the 
diﬀ erence in costs using standard methods.
We used SAS (version 9.3) for the analyses. This trial 
is registered, number ISRCTN25729565.
Role of the funding source
The sponsors of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. A representative of the funders, 
National Prevention Research Initiative (Medical 
Research Council), was a member of the Trial Steering 
Group. Raw data were accessed by the trial manager 
(AD) and a statistician who was independent of the 
conduct of the trial (IB). The corresponding author had 
full access to all the data in the study and the ﬁ nal 
responsibility for the decision to submit for publication.
Intervention group Control group
(Continued from previous page)
Hip circumference (cm) 106·9 (9·4) 107·3 (9·6)
Waist to hip ratio 0·96 (0·06) 0·96 (0·07)
BMI category (kg/m²)
<25 9 (11%) 11 (13%)
≤25 to <30 38 (45%) 29 (34%)
≥30 38 (45%) 46 (53%)
Systolic blood pressure (mm Hg) 136·9 (21·8) 137·0 (19·7)
Diastolic blood pressure (mm Hg) 82·7 (12·5) 83·5 (10·7)
Fasting plasma glucose (mmol/L) 5·8 (0·6) 5·8 (0·6)
2-h plasma glucose (mmol/L) 8·2 (1·6) 8·3 (1·5)
Present medications
Cholesterol lowering 14 (16%) 25 (29%)
Antihypertensive 21 (25%) 27 (31%)
Data are n (%) or mean (SD) unless otherwise speciﬁ ed. IGT=impaired glucose tolerance. IFG=impaired fasting glucose. 
IPAQ=International Physical Activity Questionnaire. *MET.min is metabolic equivalents calculated as vigorous activity 
× 8, moderate activity × 4, and walking × 3·3. 
Table 1: Baseline characteristics of families and participants
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Results
2089 people were referred for screening, 1319 of whom 
were eligible, available, and agreed to be screened. The 
community-orientated, personal approaches to recruit-
ment were the most successful yielding 1728 referrals 
(83%) to the screening stage. The response to written 
invitations via general practitioners was comparatively 
low at 265 of 5071 (5%). Of 1319 people who were 
screened (including an oral glucose tolerance test), 
196 (15%) had impaired glucose tolerance or impaired 
fasting glucose and 171 entered the trial as participants 
(ﬁ gure 1). The participants and 124 family volunteers 
were in 156 family clusters that were randomised 
(78 families with 85 participants and 55 family volunteers 
were allocated to intervention; 78 families with 
86 participants and 69 family volunteers were allocated 
to control). 167 (98%) participants in 152 families and 118 
(95%) family volunteers completed the trial.
Table 1 shows that at baseline the groups were much 
the same in terms of number of recruits per family and 
proportion with family volunteers. Details of recruitment 
and baseline characteristics have been reported 
previously.15,25 The groups were much the same in terms 
of individual level variables, except for physical activity 
(more in intervention group) and cholesterol-lowering 
medication (less in intervention group). The 
characteristics of family volunteers were much the same 
in the two groups (appendix pp 5–6).
Data completeness for key variables was almost 100% 
(appendix p 7) and the dietitian visits were mostly 
completed as planned for participants (appendix p 8): 
the mean number of visits for the intervention group 
was 13·7 (SD 2·1) and for the control group was 3·9 
(SD 0·3). The main reason for missed visits was being 
away from home. Family volunteers were usually 
present at annual visits but not at other visits (appendix 
Baseline Year 1 Year 2 Year 3 Adjusted mean diﬀ erence 
(95% CI)
p value
Anthropometry
Weight (kg)
Intervention 79·77 (16·23) 78·82 (16·11) 79·09 (15·94) 78·76 (16·57) –1·64 (–2·83 to –0·44) 0·0076
Control 80·68 (14·98) 80·36 (14·80) 80·96 (15·10) 80·99 (15·34) ·· ··
BMI (kg/m²)
Intervention 30·59 (5·02) 30·18 (5·04) 30·31 (5·15) 30·18 (5·50) –0·60 (–1·06 to –0·14) 0·0112
Control 30·49 (4.60) 30·39 (4·56) 30·57 (4·84) 30·65 (4·83) ·· ··
Waist circumference (cm)
Intervention 102·69 (11·16) 101·55 (11·34) 102·04 (11·22) 100·51 (11·51) –1·89 (–3·27 to –0·52) 0·0072
Control 103·26 (11·01) 103·45 (11·66) 103·43 (11·19) 102·85 (11·14) ·· ··
Hip circumference (cm)
Intervention 106·85 (9·43) 105·68 (9·53) 105·95 (9·64) 104·48 (9·77) –1·54 (–2·71 to –0·37) 0·0101
Control 107·34 (9·55) 106·90 (9·23) 107·26 (9·91) 106·67 (9·16) ·· ··
Waist to hip ratio
Intervention 0·96 (0·06) 0·96 (0·07) 0·96 (0·07) 0·96 (0·07) –0·00 (–0·01 to 0·01) 0·6756
Control 0·96 (0·07) 0·97 (0·07) 0·97 (0·07) 0·96 (0·06) ·· ··
Glycaemia
Fasting plasma glucose (mmol/L)
Intervention 5·77 (0·61) ·· ·· 5·84 (0·77) –0·13 (–0·39 to 0·13) 0·3361
Control 5·82 (0·61) ·· ·· 5·98 (1·04) ·· ··
2-h plasma glucose (mmol/L)
Intervention 8·21 (1·63)  ··  ·· 7·38 (2·49) –0·56 (–1·32 to 0·19) 0·1428
Control 8·33 (1·51)  ·· ·· 8·05 (2·56) ·· ··
Blood pressure
Systolic (mm Hg)
Intervention 136·9 (21·78) 135·7 (16·64) 135·6 (18·40) 137·2 (18·73)  –1·19 (–5·50 to 3·12) 0·5856
Control 137·0 (19·66) 137·0 (19·55) 135·7 (16·21) 138·8 (17·95) ·· ··
Diastolic (mm Hg)
Intervention 82·7 (12·51) 81·6 (10·09) 80·8 (10·66) 81·3 (10·72)  –0·45 (–3·26 to 2·36) 0·7541
Control 83·5 (10·69) 82·6 (12·18) 81·6 (10·34) 82·7 (11·23) ·· ··
N=84 for intervention group; N=83 for control group. Data are mean (SD) unless otherwise speciﬁ ed. Mean diﬀ erences are adjusted for stratiﬁ cation variables at 
randomisation (ethnic group, city) and for corresponding baseline value.
Table 2: Comparison between anthropometric, glycaemic, and blood pressure measures
See Online for appendix
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p 8). One participant and two family volunteers in the 
intervention group, and three participants and four 
family volunteers in the control group died or were lost 
to follow-up and were excluded from the analyses 
(ﬁ gure 1). 
Table 2 and ﬁ gure 2A show that participants in the 
intervention group lost more weight than those in the 
control group by year 1 and sustained this advantage at 
year 3. The control group lost weight in year 1 but gained 
weight overall (mean weight loss in the intervention 
group was 1·13 kg [SD 4·12], compared with mean 
weight gain of 0·51 kg [3·65] in the control group). The 
adjusted mean diﬀ erence at 3 years was –1·64 kg (95% CI 
–2·83 to –0·44) for the intervention group compared 
with the control group (p=0·0076). Secondary analysis 
including adjustment for baseline IPAQ activity category 
(low, moderate, or high) gave an adjusted mean diﬀ erence 
of –1·64 kg (95% CI –2·89 to –0·40). Secondary analysis 
using dietitians’ measures of 3-year weight gave an 
adjusted mean diﬀ erence of –1·64 kg (–2·84 to –0·44). 
The pattern was much the same for BMI (table 2), waist 
circumference (table 2, ﬁ gure 2B), and hip circumference 
(table 2). Fasting glucose increased slightly in both 
Number 
(%)
Adjusted odds 
ratio (95% CI)
p value
Diabetes*
Progression to type 2 diabetes
Intervention 12 (15%) 0·68 (0·27–1·67) 0·3705
Control 17 (21%) ·· ··
Doctor diagnosed
Intervention 10 (12%) ·· ··
Control 10 (12%) ·· ··
Based on 3 year OGTT
Intervention 2 (2%) ·· ··
Control 7 (9%) ·· ··
Reverting to NGT
Intervention 36 (44%) 1·23 (0·62–2·47) 0·5294
Control 32 (39%) ·· ··
Weight change†
Losing ≥2·5 kg
Intervention 33 (39%) 3·92 (1·68–9·13) 0·0036
Control 12 (14%) ·· ··
Losing ≥5% of bodyweight
Intervention 21 (25%) 6·57 (1·92–22·44) 0·0052
Control 4 (5%) ·· ··
Gaining ≥2·5 kg
Intervention 19 (23%) 1·23 (0·55–2·79) 0·5895
Control 16 (19%) ·· ··
Gaining ≥5% of bodyweight
Intervention 8 (10%) 0·86 (0·29–2·57) 0·7706
Control 9 (11%) ·· ··
Odds ratios are adjusted for stratiﬁ cation variables at randomisation (ethnic 
group, city). OGTT=oral glucose tolerance test. NGT=normal glucose tolerance. 
*N=81 for intervention group; N=82 for control group. †N=84 for intervention 
group; N=83 for control group. 
Table 3: Comparison between secondary outcomes relating to diabetes 
and weight change
Figure 2: Mean change in (A) weight and (B) waist circumference from 
baseline over 3 years
Error bars are 95% CI.
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groups whereas 2 h glucose decreased slightly in both 
groups but neither diﬀ erence was statistically signiﬁ cant 
(table 2). Blood pressure remained stable in both groups 
(table 2).
For family volunteers, weight and other measures of 
adiposity were mostly stable with no signiﬁ cant diﬀ erences 
between the two groups (appendix p 9).
At 3 years, the proportion of participants who had lost 
2·5 kg was higher in the intervention group than the 
control group (table 3) as was the proportion who had lost 
5% of their bodyweight (table 3). Weight gain was 
common in both groups, with 23% of participants in the 
intervention group and 19% in the control group gaining 
2·5 kg or more (table 3). Table 4 shows that there was little 
diﬀ erence between groups at 3 years in participants 
reporting physical activity at the recommended level, with 
increases between baseline and year 1 in the intervention 
group and between year 2 and year 3 in the control group.
Progression to diabetes (either doctor diagnosed or by 
oral glucose tolerance test at 3 years) was observed less 
frequently in the intervention group than the control 
group (OR 0·68) but the diﬀ erence was not statistically 
signiﬁ cant (95% CI 0·27–1·67; p=0·3705; table 3).
Table 5 shows that 3-year dietitian costs were £1190 for 
the intervention group and £575 for the control group; 
annual times and costs are in appendix p 10. The total 
extra 3-year mean cost for the intervention group was 
£1126 (95% CI –2414 to 4666), with £615 of that diﬀ erence 
being dietitian costs, £324 being NHS general practice 
and hospital outpatient costs, and £207 being indirect 
opportunity costs to participants (table 5). Indirect costs 
were attributable to additional physical activity time, not 
food preparation or shopping time (appendix pp 10–11). 
The intervention group had 12·4 h of dietitian contact 
per family, which required 17·8 h of preparation and 
travel time—totalling 30·2 h, about double that in the 
control group (appendix p 10). Primary-care visits and 
costs did not diﬀ er between groups, but there were more 
outpatient visits in the intervention group than in the 
control group (costing £327 more; appendix p 10).
Seven adverse events were perceived by participants to 
be attributable to the intervention (three in the intervention 
group, four in the control group). Five were mild and two 
were moderate. The moderate events, deﬁ ned as 
interfering with routine activity, were: arthritis in the knee 
causing pain on walking and worries about changing 
habits—both occurred in the intervention group.
Discussion
In this study of 171 individuals of south Asian descent 
living in the UK, a culturally adapted, family-based 
lifestyle intervention consisting of about 15 visits from a 
dietitian over 3 years resulted in signiﬁ cantly greater 
weight loss than did annual contact and simple lifestyle 
Baseline Year 1 Year 2 Year 3 Adjusted odds 
ratio (95% CI)
Diﬀ erence in 
medians† (95% CI)
p value
MET.min*
Intervention 446 (66–1095) 594 (231–1154) 528 (165–1200) 596 (198–1512) ·· 156·0 (0·0 to 343·0) 0·0676
Control 281 (120–660) 398 (120–743) 273 (73–578) 396 (99–1026) ·· ·· ··
Total physical activity (min per day)
Intervention 125·0 (20–300) 180·0 (70–315) 150·0 (50–315) 175·0 (60–420) ·· 40·0 (0.0 to 95·0) 0·0751
Control 75·0 (30–180) 118 (30–195) 80·0 (20–160) 120·0 (30–280) ·· ·· ··
Sitting time (h per day)
Intervention 6·0 (4–8) 6·0 (5–8) 6·0 (5–8) 6·0 (4–7) ·· –1·0 (–2·0 to 0·0) 0·0523
Control 6·0 (4–9) 6·0 (4–9) 7·0 (5–9) 7·0 (5–8) ·· ·· ··
Number achieving ≥30 min activity per day
Intervention 32/84 (38%) 38/81 (47%) 32/83 (39%) 36/84 (43%) 1·14 (0·53 to 2·47) ·· 0·7201
Control 17/83 (20%) 20/82 (24%) 13/83 (16%) 29/83 (35%) ·· ·· ··
Number achieving ≥150 min activity per week
Intervention 39/85 (46%) 48/81 (59%) 42/83 (51%) 46/84 (55%) 1·19 (0·55 to 2·55) ·· 0·6382
Control 24/86 (28%) 30/82 (37%) 26/83 (31%) 37/83 (45%) ·· ·· ··
Data are median (IQR) or n (%). *MET.min is metabolic equivalents calculated as vigorous activity × 8, moderate activity × 4, and walking × 3·3. †Diﬀ erence in median activity between groups at the ﬁ nal 
timepoint only, using a Mann Whitney test to for account the skewed nature of the values.
Table 4: Comparison between groups of physical activity outcomes
Intervention Control Mean diﬀ erence (95% CI) p value
Dietitians £1190 £575 £615 (561 to 668) <0·0001
NHS general practice £1045 £1068 £–23 (–235 to 189) 0·9999
NHS hospital outpatient £1235 £908 £327 (–107 to 762) 0·1405
Dietitian and NHS costs combined £3470 £2551 £919 (360 to 1478) 0·0013
Costs to participants £14 643 £14 437 £207 (–3267 to 3681) 0·9145
Total £18 113 £16 988 £1126 (–2414 to 4666) 0·5441
Mean 3-year costs per participant to the health service (dietitian visits, NHS general practice and outpatient services), 
and cost to participants relating to physical activity and food shopping and preparation by group. N=84 for 
intervention group; N=83 for control group. NHS=National Health Service.
Table 5: Cost analysis
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advice from a dietitian (control). Reductions in BMI and 
waist and hip circumferences were also signiﬁ cantly 
greater in the intervention group. The proportion of 
individuals who lost 2·5 kg over 3 years was higher in 
the intervention group than in the control group, as was 
the proportion who lost 5% of their bodyweight. 
However, about 20% of participants in both groups 
gained 2·5 kg during the course of the study. Progression 
to diabetes was observed less frequently in the 
intervention group than the control group, but the 
diﬀ erence was not statistically signiﬁ cant. A cost analysis 
showed that the additional 3-year cost of the intervention 
in terms of health-service costs and indirect costs to 
participants was £1126 per participant.
Individuals tend to gain weight as they age,12,26 
especially after immigration from developing to 
developed countries. Our trial shows that provision of 
simple information about diet and lifestyle (as in the 
control group and family volunteers) did not stop this 
tendency whereas a tailored, moderate-intensity 
intervention targeted at those at high risk of developing 
diabetes counteracted it. The intervention led to modest 
but sustained weight loss, substantially increased the 
likelihood of losing at least 2·5 kg, and decreased waist 
and hip circumferences. These beneﬁ ts need to be oﬀ set 
against the direct (health care) costs and opportunity 
costs for participants. Weight loss of 0·5–2·5 kg, 
especially centrally as shown by a decrease in waist 
circumference, when combined with some increase in 
physical activity,26–29 has beneﬁ cial eﬀ ects on metabolic 
variables, including potentially enhancing the uptake of 
glucose by adipose tissue.9,26,29,30 Our results showing 
little diﬀ erence between intervention and control groups 
in outcomes such as fasting glucose, 2-h postprandial-
glucose, and blood pressure, are in line with ﬁ ndings at 
3 years from other studies, especially those with similar 
weight loss.8,10,29,31–33 In view of the sensitivity of individuals 
from south Asia from childhood onwards to metabolic 
disturbances associated with adiposity, weight loss 
might have equivalent or greater beneﬁ ts than in 
populations of European ancestry, although the opposite 
view has also been postulated.34 Weight loss had similar 
beneﬁ ts in a range of ethnic groups in the US Diabetes 
Prevention Programme.9 Sakane and colleagues30 
showed a 54% decrease in diabetes incidence, even 
though weight loss was small, and postulated that their 
Japanese population was especially sensitive to adiposity, 
perhaps through loss of liver fat.
Our trial diﬀ ered from others in several ways.8 For 
example, the intervention was home-based and delivered 
by dietitians and not by clinic-based staﬀ , families not 
individuals were randomised, and the support of the 
family cook was mandatory for enrolment.19 Dietitians 
also played a central part in most similar trials (eg, the US 
Diabetes Prevention Programme9 and Finnish Diabetes 
Prevention Study8). A family focus is widely recommended 
(eg, by National Institute for Health and Care Excellence6) 
but trials adopting this recommendation are rare. Family 
involvement was judged especially important in south 
Asian individuals in view of the strong cultural emphasis 
on family life, eating together, and obligations in 
hospitality, points emphasised in national guidelines.35 
However, we were not able to recruit family volunteers for 
many families. The added value of family involvement 
remains to be explored in future studies.
The number of contacts with a dietitian in the 
intervention group in the present trial emulated the 
Finnish diabetes prevention study8 but the content was 
less intensive and more focused on food and walking. 
The intensity of the intervention was much less than in 
the US Diabetes Prevention Programme9 but was about 
the same as that in the Indian Diabetes Prevention 
Programme.2 Our intervention led to smaller changes 
in weight, physical activity, and progression to diabetes 
than in the US9 and Finnish8 programmes. Our results 
are, however, not outliers but are much the same as 
those for a culturally adapted diabetes prevention 
programme for Latinos in the USA at 1 year36 and in the 
SLIM trial at 3 years.31 In the Indian Diabetes Prevention 
Programme2 in which participants did not lose weight 
overall, participants had lower BMIs at baseline than 
those in the present study (average 25·7 kg/m² in the 
lifestyle intervention group, compared with 30·6 kg/m² 
Panel: Research in context
Systematic review
We searched Google Scholar and PubMed/Medline for reports published between Jan 1, 
2009, and June 11, 2013, using combinations of the key words “Indian”, “Pakistani”, 
“south Asian”, “diabetes”, “prediabetes prevention”, “weight loss”, “physical activity”, 
“impaired glucose tolerance”, and “impaired fasting glucose”. We contacted chief 
investigators of the DHIANN37 and Bangladip studies and examined the abstracts of the 
World Congress of Diabetes Prevention, 2012.
We identiﬁ ed both systematic and narrative reviews of lifestyle interventions for prevention 
of progression from impaired glucose tolerance and impaired fasting glucose to 
diabetes;6,10,14 nutrition interventions;39 weight management;12,39–41 promotion of physical 
activity;4 and on diabetes in south Asian individuals, including evidence for lifestyle 
interventions in people from south Asia.3 One trial, the India Diabetes Prevention 
Programme,2 included people with impaired fasting glucose and impaired glucose tolerance 
and reported 3-year outcomes.
Interpretation
Intensive interventions to prevent progression to diabetes in those with impaired glucose 
tolerance or impaired fasting glucose through lifestyle change are generally eﬀ ective and 
probably cost eﬀ ective. The scientiﬁ c literature shows the diﬃ  culty of intervening to 
reduce weight (not achieved in the Indian Diabetes Prevention Programme2), prevent 
weight gain, and increase physical activity in south Asian individuals.3,4,41 The present study 
shows that a medium-intensity lifestyle intervention leads to modest but sustained 
weight loss at 3-year follow-up in south Asian individuals in the UK. A meta-analysis of 
studies of south Asian populations might be possible after D-CLIP42 and DHIANN37 report 
ﬁ nal-year results. Pending further research, policy makers and practitioners should note 
that the materials and approaches used in the present study might help to combat 
adiposity-related disorders but, alone, are an insuﬃ  cient strategy.
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in the present trial). A primary care based trial in south 
Asian individuals in the Netherlands had an intervention 
of similar intensity to the present trial, with 0·2 kg 
weight loss in the intervention group, and no changes 
in metabolic proﬁ les at 1 year, with no signiﬁ cant 
diﬀ erences compared with controls.37 In a non-
randomised assessment of 140 south Asian participants 
in Khush Dil, a community clinic service intervention 
in Edinburgh, weight loss at 6-months was about 
0·61 kg compared with baseline.38 More than 20% of 
participants in the present trial, including in the 
intervention group, gained more than 2·5 kg over 3 
years. We have not found similar data for weight gain 
from other studies.
The estimate of the eﬀ ect size on progression to 
diabetes (OR 0·68, 95% CI 0·27–1·67) was in line with 
that in the Indian Diabetes Prevention Programme (28% 
lower risk) and with predictions of reductions in 
type 2 diabetes on the basis of the eﬀ ect of small amounts 
of weight loss in the Finnish US diabetes prevention 
programmes.26 However, the diﬀ erence we observed 
between groups was not statistically signiﬁ cant.
As far as we are aware, the present trial was the ﬁ rst 
culturally adapted, community-based, randomised trial of 
its kind outside India but it aligns with much existing 
guidance on interventions.3,6 The strengths of the trial 
include cross-cultural adaptation,19 the quality of data, 
involvement of the family, and high attendance and 
retention. Weaknesses include alteration to the primary 
outcome, the modest sample size, and absence of objective 
measures of physical activity, although the IPAQ has been 
validated against accelerometry.22 Other limitations 
include that the trial only measured glucose at two 
timepoints, and there was no measure of insulin or HbA1c. 
Our attempts to engage several members in each family 
met with little success, with little clustering within 
families of people with impaired fasting glucose or 
impaired glucose tolerance and an inability to recruit 
family volunteers in many families. Future work should 
investigate why some people lose weight and others gain 
weight, even in an intervention group; long-term 
outcomes (through data linkage); cost-eﬀ ectiveness of 
interventions in south Asian individuals through meta-
analyses (panel); the added value of family-based and 
home-based interventions compared with individual, 
clinic-based interventions; and how interventions can be 
improved. Our trial will contribute to future debates on 
these matters.
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